VWA
SRNE

VSM Wealth Advisory’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

VSM Wealth Advisory’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66 Hold
110,100
– – ﹤0.01% 499
2026
Q1 		$363 Buy
+110,100
New +$363 ﹤0.01% 479

Other funds holding SRNE

HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

VSM Wealth Advisory's SRNE Position: Q2 2026 in Review

VSM Wealth Advisory held its Sorrento Therapeutics, Inc. (SRNE) position steady in Q2 2026 at 110,100 shares worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #499.

VSM Wealth Advisory first reported a position in SRNE in Q1 2026 and has held it in 2 quarters since. The position peaked at $363 in Q1 2026. 5 funds tracked by Wall St. Rank hold SRNE as of Q2 2026.

  • VSM Wealth Advisory held 110,100 shares of Sorrento Therapeutics, Inc. worth $66 as of Q2 2026.
  • VSM Wealth Advisory left its Sorrento Therapeutics, Inc. share count unchanged in Q2 2026.
  • Sorrento Therapeutics, Inc. made up ﹤0.01% of VSM Wealth Advisory's portfolio in Q2 2026, its #499 holding.
  • VSM Wealth Advisory first reported a position in Sorrento Therapeutics, Inc. in Q1 2026 and has held it in 2 quarters since.
  • VSM Wealth Advisory's Sorrento Therapeutics, Inc. position peaked at $363 in Q1 2026.
  • 5 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2026.

Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.